989 related articles for article (PubMed ID: 16554806)
1. hERG potassium channels and cardiac arrhythmia.
Sanguinetti MC; Tristani-Firouzi M
Nature; 2006 Mar; 440(7083):463-9. PubMed ID: 16554806
[TBL] [Abstract][Full Text] [Related]
2. The cardiac hERG/IKr potassium channel as pharmacological target: structure, function, regulation, and clinical applications.
Thomas D; Karle CA; Kiehn J
Curr Pharm Des; 2006; 12(18):2271-83. PubMed ID: 16787254
[TBL] [Abstract][Full Text] [Related]
3. [HERG K+ channel, the target of anti-arrhythmias drugs].
Guan FY; Yang SJ
Yao Xue Xue Bao; 2007 Jul; 42(7):687-91. PubMed ID: 17882949
[TBL] [Abstract][Full Text] [Related]
4. Human ether-a-go-go related gene (hERG) K+ channels: function and dysfunction.
Perrin MJ; Subbiah RN; Vandenberg JI; Hill AP
Prog Biophys Mol Biol; 2008; 98(2-3):137-48. PubMed ID: 19027781
[TBL] [Abstract][Full Text] [Related]
5. hERG potassium channels and the structural basis of drug-induced arrhythmias.
Mitcheson JS
Chem Res Toxicol; 2008 May; 21(5):1005-10. PubMed ID: 18447395
[TBL] [Abstract][Full Text] [Related]
6. The Susceptibilities of Human Ether-à-Go-Go-Related Gene Channel with the G487R Mutation to Arrhythmogenic Factors.
Hisajima N; Hata Y; Kinoshita K; Fukushima T; Nishida N; Kano M; Tabata T
Biol Pharm Bull; 2015; 38(5):781-4. PubMed ID: 25947924
[TBL] [Abstract][Full Text] [Related]
7. The hERG potassium channel as a therapeutic target.
Witchel HJ
Expert Opin Ther Targets; 2007 Mar; 11(3):321-36. PubMed ID: 17298291
[TBL] [Abstract][Full Text] [Related]
8. Disopyramide is an effective inhibitor of mutant HERG K+ channels involved in variant 1 short QT syndrome.
McPate MJ; Duncan RS; Witchel HJ; Hancox JC
J Mol Cell Cardiol; 2006 Sep; 41(3):563-6. PubMed ID: 16842817
[TBL] [Abstract][Full Text] [Related]
9. C-terminal HERG (LQT2) mutations disrupt IKr channel regulation through 14-3-3epsilon.
Choe CU; Schulze-Bahr E; Neu A; Xu J; Zhu ZI; Sauter K; Bähring R; Priori S; Guicheney P; Mönnig G; Neapolitano C; Heidemann J; Clancy CE; Pongs O; Isbrandt D
Hum Mol Genet; 2006 Oct; 15(19):2888-902. PubMed ID: 16923798
[TBL] [Abstract][Full Text] [Related]
10. A recombinant N-terminal domain fully restores deactivation gating in N-truncated and long QT syndrome mutant hERG potassium channels.
Gustina AS; Trudeau MC
Proc Natl Acad Sci U S A; 2009 Aug; 106(31):13082-7. PubMed ID: 19651618
[TBL] [Abstract][Full Text] [Related]
11. Getting to the heart of hERG K(+) channel gating.
Perry MD; Ng CA; Mann SA; Sadrieh A; Imtiaz M; Hill AP; Vandenberg JI
J Physiol; 2015 Jun; 593(12):2575-85. PubMed ID: 25820318
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of the HERG channel by droperidol depends on channel gating and involves the S6 residue F656.
Luo T; Luo A; Liu M; Liu X
Anesth Analg; 2008 Apr; 106(4):1161-70, table of contents. PubMed ID: 18349188
[TBL] [Abstract][Full Text] [Related]
13. Modeling HERG and its interactions with drugs: recent advances in light of current potassium channel simulations.
Recanatini M; Cavalli A; Masetti M
ChemMedChem; 2008 Apr; 3(4):523-35. PubMed ID: 18224703
[TBL] [Abstract][Full Text] [Related]
14. An NMR investigation of the structure, function and role of the hERG channel selectivity filter in the long QT syndrome.
Gravel AE; Arnold AA; Dufourc EJ; Marcotte I
Biochim Biophys Acta; 2013 Jun; 1828(6):1494-502. PubMed ID: 23473737
[TBL] [Abstract][Full Text] [Related]
15. hERG trafficking inhibition in drug-induced lethal cardiac arrhythmia.
Nogawa H; Kawai T
Eur J Pharmacol; 2014 Oct; 741():336-9. PubMed ID: 24998878
[TBL] [Abstract][Full Text] [Related]
16. The inhibitory effect of the antipsychotic drug haloperidol on HERG potassium channels expressed in Xenopus oocytes.
Suessbrich H; Schönherr R; Heinemann SH; Attali B; Lang F; Busch AE
Br J Pharmacol; 1997 Mar; 120(5):968-74. PubMed ID: 9138706
[TBL] [Abstract][Full Text] [Related]
17. In silico prediction of the chemical block of human ether-a-go-go-related gene (hERG) K+ current.
Inanobe A; Kamiya N; Murakami S; Fukunishi Y; Nakamura H; Kurachi Y
J Physiol Sci; 2008 Dec; 58(7):459-70. PubMed ID: 19032804
[TBL] [Abstract][Full Text] [Related]
18. hERG K(+) channels: structure, function, and clinical significance.
Vandenberg JI; Perry MD; Perrin MJ; Mann SA; Ke Y; Hill AP
Physiol Rev; 2012 Jul; 92(3):1393-478. PubMed ID: 22988594
[TBL] [Abstract][Full Text] [Related]
19. Long QT syndrome-associated I593R mutation in HERG potassium channel activates ER stress pathways.
Keller SH; Platoshyn O; Yuan JX
Cell Biochem Biophys; 2005; 43(3):365-77. PubMed ID: 16244363
[TBL] [Abstract][Full Text] [Related]
20. Collation, assessment and analysis of literature in vitro data on hERG receptor blocking potency for subsequent modeling of drugs' cardiotoxic properties.
Polak S; Wiśniowska B; Brandys J
J Appl Toxicol; 2009 Apr; 29(3):183-206. PubMed ID: 18988205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
